Shannon Pendergrast's guest appearances

Shannon Pendergrast

Finding Genius Podcast

FutureTech Podcast

J Scott

Danny Flood

Perry Marshall

Ross Taylor

Mark Bertin

Elisha Goldstein

Scott Nelson

Robin Smith

Cassie Bjork

Andreas Eenfeldt

Hannah Crum

Naveen Jain

Andrew Walker

Eric Boduch

Alex Lewin

OwlTail

Ymir Genomics

In this thorough and informative podcast, P. Shannon Pendergrast, PhD, Chief Science Officer at Ymir Genomics (ymirgenomics.com), provides an overview of biomarker identification techniques and his company’s work. Dr. Pendergrast earned a PhD from the Rutgers University Waksman Institute of Microbiology in Molecular Genetics then went on to pursue post-doctoral training at Cold Spring Harbor Laboratories. As a scientist, executive, and entrepreneur, Dr. Pendergrast seeks to utilize all his experience to help in the fight against disease. Dr. Pendergrast discusses their company, Ymir Genomics, and its long range mission and goals. Ymir Genomics delivers advanced tools that can support the discovery of biomarkers from biofluids. Dr. Pendergrast discusses their work and important discoveries, including the rapid method for isolating extracellular vesicles, extracellular RNA, and/or extracellular protein, straight from urine samples. The researcher provides extensive information on extracellular vesicles (EVs), which are membrane-derived vesicles that can be released through various cell types, such as hepatic stellate cells, hepatocytes, and of course immune cells, in normal, and pathological, conditions. The science CSO explains how they study and compare proteins via the use of mass spectrometry. And Dr. Pendergrast discusses their work studying liver-specific vesicles, stability issues, exosomes, and so much more, highlighting how they can work with structures, proteins, and RNA. In this podcast:  What can we learn from biomarkers? What are extracellular vesicles? The importance of proper biomarker identification techniques 

In this thorough and informative podcast, P. Shannon Pendergrast, PhD, Chief Science Officer at Ymir Genomics (<a href="http://ymirgenomics.com/" rel="nofollow" target="_blank">ymirgenomics.com</a>), provides an overview of biomarker identification techniques and his company’s work. Dr. Pendergrast earned a PhD from the Rutgers University Waksman Institute of Microbiology in Molecular Genetics then went on to pursue post-doctoral training at Cold Spring Harbor Laboratories. As a scientist, executive, and entrepreneur, Dr. Pendergrast seeks to utilize all his experience to help in the fight against disease. Dr. Pendergrast discusses their company, Ymir Genomics, and its long range mission and goals. Ymir Genomics delivers advanced tools that can support the discovery of biomarkers from biofluids. Dr. Pendergrast discusses their work and important discoveries, including the rapid method for isolating extracellular vesicles, extracellular RNA, and/or extracellular protein, straight from urine samples. The researcher provides extensive information on extracellular vesicles (EVs), which are membrane-derived vesicles that can be released through various cell types, such as hepatic stellate cells, hepatocytes, and of course immune cells, in normal, and pathological, conditions. The science CSO explains how they study and compare proteins via the use of mass spectrometry. And Dr. Pendergrast discusses their work studying liver-specific vesicles, stability issues, exosomes, and so much more, highlighting how they can work with structures, proteins, and RNA. In this podcast: <ul> <li>What can we learn from biomarkers?</li> <li>What are extracellular vesicles?</li> <li>The importance of proper biomarker identification techniques</li> </ul>

Biomarker Identification Techniques – P. Shannon Pendergrast, PhD, CSO of Ymir Genomics – EVs and Fighting Disease

P. Shannon Pendergrast, PhD, Chief Science Officer at Ymir Genomics (ymirgenomics.com), discusses his company’s work in biomarker identification techniques. Dr. Pendergrast holds a PhD from the Rutgers University Waksman Institute of Microbiology in Molecular Genetics. He completed his post-doctoral training at Cold Spring Harbor Laboratories. Dr. Pendergrast has over 12 years of experience as a scientist, executive, and entrepreneur. Ymir Genomics seeks to provide new and innovative tools to facilitate the discovery of biomarkers from biofluids, to assist in the ongoing fight against human diseases. Dr. Pendergrast discusses the primary objectives of Ymir Genomics. Dr. Pendergrast talks in detail about their accomplishments and discoveries, including their efficient, rapid method for isolating extracellular vesicles, extracellular RNA, and/or extracellular protein directly from urine samples. Extracellular vesicles (EVs) are membrane-derived vesicles that can be released via different cell types, including hepatic stellate cells, hepatocytes, and immune cells in normal as well as pathological conditions. The science researcher CSO discusses how they compare proteins using mass spectrometry, and how they look at the data. He talks in detail about their work studying liver-specific vesicles, exosomes, stability issues, and more. He discusses their processes in detail, discussing how they work with structures, proteins, RNA, etc. Among the many important offerings Ymir delivers, they can also provide extracellular vesicle isolation protocol and bioinformatics protocol to discover biomarkers for prostate and bladder cancer. Dr. Pendergrast wraps up by discussing their current and future work. In this podcast: What can we learn from extracellular vesicles? What can biomarkers tell us? An overview of biomarker identification techniques

P. Shannon Pendergrast, PhD, Chief Science Officer at Ymir Genomics (<a href="http://ymirgenomics.com" rel="nofollow" target="_blank">ymirgenomics.com</a>), discusses his company’s work in biomarker identification techniques. Dr. Pendergrast holds a PhD from the Rutgers University Waksman Institute of Microbiology in Molecular Genetics. He completed his post-doctoral training at Cold Spring Harbor Laboratories. Dr. Pendergrast has over 12 years of experience as a scientist, executive, and entrepreneur. Ymir Genomics seeks to provide new and innovative tools to facilitate the discovery of biomarkers from biofluids, to assist in the ongoing fight against human diseases. Dr. Pendergrast discusses the primary objectives of Ymir Genomics. Dr. Pendergrast talks in detail about their accomplishments and discoveries, including their efficient, rapid method for isolating extracellular vesicles, extracellular RNA, and/or extracellular protein directly from urine samples. Extracellular vesicles (EVs) are membrane-derived vesicles that can be released via different cell types, including hepatic stellate cells, hepatocytes, and immune cells in normal as well as pathological conditions. The science researcher CSO discusses how they compare proteins using mass spectrometry, and how they look at the data. He talks in detail about their work studying liver-specific vesicles, exosomes, stability issues, and more. He discusses their processes in detail, discussing how they work with structures, proteins, RNA, etc. Among the many important offerings Ymir delivers, they can also provide extracellular vesicle isolation protocol and bioinformatics protocol to discover biomarkers for prostate and bladder cancer. Dr. Pendergrast wraps up by discussing their current and future work. In this podcast: What can we learn from extracellular vesicles? What can biomarkers tell us? An overview of biomarker identification techniques

Biomarker Discovery – P. Shannon Pendergrast